Overview

• The award includes £275,000 from Scottish Enterprise and just over £200,000 from the Medical Research Council’s Gap Fund to move the technology into clinical testing and toward a spin-out.
• Researchers will begin evaluating the sensor in patients with moderate eczema who are on third- or fourth-line treatments.
• Clinical work will collect usability feedback from patients and clinicians while aligning sensor readings with specialist dermatologist assessments.
• The approach targets the shortcomings of visual checks by providing quantitative measures that do not depend on skin color.
• If trials succeed, the team says the tool could support treatment tracking and point-of-care assessments in pharmacies and community clinics, easing demand on specialist services.